Insider trading of Life Science Ventures Vi Gm..., a at ACER Acer Therapeutics Inc.
Most recently Life Science Ventures Vi Gm... bought 333,333 shares worth $3,999,996.00 on 12 December 2017.
About Acer Therapeutics Inc.
Acer Therapeutics Inc. develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs. The company offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease (MSUD). It also offers advancing ACER-001 for the treatment of urea cycle disorders (UCD). The company was founded in 2013 and is based in Cambridge, Massachusetts.
- Acer Therapeutics Inc., 222 Third Street, Cambridge 02142, United States